Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Integrated Healthcare System01:20

Integrated Healthcare System

An integrated healthcare system (IHS) is a set of organizations that provides for or arranges to provide coordinated and continuous service to a defined population. The IHS takes responsibility for that particular population's health status and outcome, both clinically and fiscally. An integrated healthcare system is a well-organized, well-coordinated, and collaborative network. The integrated delivery system is a network that connects different healthcare providers to deliver organized,...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ecological restructuring of the nonbacterial fecal microbiome in obesity across human cohorts.

Gut microbes·2026
Same author

Amylin Analogs: The Next Major Class of Weight Loss Therapy: A Review of Experimental Data and Early-Phase Clinical Trials.

Diabetes, obesity & metabolism·2026
Same author

GxP-Ready Single-Cell RNA-seq and Spatial Transcriptomics End-to-End Pipeline for Clinical Research.

Computational and structural biotechnology journal·2026
Same author

Obesity Remission: A Missing Target in Contemporary Medicine.

Obesity reviews : an official journal of the International Association for the Study of Obesity·2026
Same author

Community pharmacists' experiences and perspectives on GLP-1 receptor agonists for obesity management: a cross-sectional study in Ireland.

The International journal of pharmacy practice·2026
Same author

A low-cost calcium silicate hydrate with an exceptionally large sequestration capacity for aqueous divalent nickel.

Scientific reports·2026

Related Experiment Video

Updated: Jun 9, 2026

FIBS-enabled Noninvasive Metabolic Profiling
09:16

FIBS-enabled Noninvasive Metabolic Profiling

Published on: February 3, 2014

9.9K

A Federated Database for Obesity Research: An IMI-SOPHIA Study.

Carl Delfin1, Iulian Dragan2, Dmitry Kuznetsov2

  • 1Novo Nordisk A/S, 2860 Søborg, Denmark.

Life (Basel, Switzerland)
|February 24, 2024
PubMed
Summary

The SOPHIA project created a federated database to analyze obesity data from 16 cohorts safely. This approach enables robust biomarker discovery and personalized obesity treatment without sharing patient data.

Keywords:
bioinformaticsfederated database systemobesityremote statistical analysisrisk prediction

More Related Videos

Sample Preparation to Bioinformatics Analysis of DNA Methylation: Association Strategy for Obesity and Related Trait Studies
14:56

Sample Preparation to Bioinformatics Analysis of DNA Methylation: Association Strategy for Obesity and Related Trait Studies

Published on: May 6, 2022

4.5K
Author Spotlight: Deciphering the Cellular Mysteries of Intermuscular Adipose Tissue in Humans
05:59

Author Spotlight: Deciphering the Cellular Mysteries of Intermuscular Adipose Tissue in Humans

Published on: May 3, 2024

688

Related Experiment Videos

Last Updated: Jun 9, 2026

FIBS-enabled Noninvasive Metabolic Profiling
09:16

FIBS-enabled Noninvasive Metabolic Profiling

Published on: February 3, 2014

9.9K
Sample Preparation to Bioinformatics Analysis of DNA Methylation: Association Strategy for Obesity and Related Trait Studies
14:56

Sample Preparation to Bioinformatics Analysis of DNA Methylation: Association Strategy for Obesity and Related Trait Studies

Published on: May 6, 2022

4.5K
Author Spotlight: Deciphering the Cellular Mysteries of Intermuscular Adipose Tissue in Humans
05:59

Author Spotlight: Deciphering the Cellular Mysteries of Intermuscular Adipose Tissue in Humans

Published on: May 3, 2024

688

Area of Science:

  • Obesity research
  • Data science in healthcare
  • Biomarker discovery

Background:

  • Obesity is often misclassified as a lifestyle choice, hindering its perception as a progressive disease.
  • Effective obesity management requires better tools for stratifying patients based on disease risk and treatment response.
  • Siloed clinical data limits comprehensive analysis and biomarker discovery for obesity.

Purpose of the Study:

  • To establish a federated database for stratifying obesity phenotypes.
  • To overcome data silos and enable collaborative analysis across multiple cohorts.
  • To develop advanced tools for personalized obesity therapy.

Main Methods:

  • Implemented a federated database using open-source DataSHIELD technology.
  • Integrated 16 diverse cohorts (research, clinical trials, routine health data).
  • Utilized the R statistical environment for remote, privacy-preserving analyses.

Main Results:

  • Successfully federated data from 16 cohorts via a central gateway.
  • Performed a proof-of-concept federated linear model (BMI and systolic blood pressure).
  • Achieved point estimates comparable to traditional meta-analysis, without patient data disclosure.

Conclusions:

  • The SOPHIA federated database enables secure, large-scale data analysis for obesity research.
  • This approach facilitates reproducible biomarker discovery and personalized treatment strategies.
  • Sets a benchmark for safe, federated analysis across diverse data types and stakeholders.